Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

EDITORIAL

REVIEW

Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough

Kimberly Page-Shafer, Judith A Hahn, Paula J Lum

AIDS 2007 September 12, 21 (14): 1967-9

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Eradication of hepatitis C infection: the importance of targeting people who inject drugs. Margaret Hellard, Joseph S Doyle, Rachel Sacks-Davis, Alexander J Thompson, Emma McBryde Hepatology: Official Journal of the American Association for the Study of Liver Diseases 2014, 59 (2): 366-9

A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. Richard S Garfein, Elizabeth T Golub, Alan E Greenberg, Holly Hagan, Debra L Hanson, Sharon M Hudson, Farzana Kapadia, Mary H Latka, Lawrence J Ouellet, David W Purcell, Steffanie A Strathdee, Hanne Thiede et al. AIDS 2007 September 12, 21 (14): 1923-32

Hepatitis vaccination among drug users. Gianluca Quaglio, Fabio Lugoboni, Paolo Mezzelani, Don C Des Jarlais, Alessandro Lechi Vaccine 2006 April 5, 24 (15): 2702-9

Updating the infection risk reduction hierarchy: preventing transition into injection. David Vlahov, Crystal M Fuller, Danielle C Ompad, Sandro Galea, Don C Des Jarlais Journal of Urban Health 2004, 81 (1): 14-9

Prevention of hepatitis C virus infection. R S Koff Clinics in Liver Disease 1997, 1 (3): 603-13

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. Nathalie Removille, Alain Origer, Sophie Couffignal, Michel Vaillant, Jean-Claude Schmit, Marie-Lise Lair BMC Public Health 2011, 11: 351

Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal. Elise Roy, Eva Nonn, Nancy Haley, Joseph Cox International Journal on Drug Policy 2007, 18 (5): 397-405

Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. Richard D Burt, Holly Hagan, Richard S Garfein, Keith Sabin, Cindy Weinbaum, Hanne Thiede Journal of Urban Health 2007, 84 (3): 436-54

Hepatitis C virus transmission dynamics in injection drug users. H Hagan Substance Use & Misuse 1998, 33 (5): 1197-212

Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT). Robert E Booth, Steffanie A Strathdee Drug and Alcohol Dependence 2007, 91: S1-3

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips